{"id":180584,"date":"2015-02-04T21:53:21","date_gmt":"2015-02-05T02:53:21","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/an-end-to-the-medicine-dropper-for-eye-injuries.php"},"modified":"2015-02-04T21:53:21","modified_gmt":"2015-02-05T02:53:21","slug":"an-end-to-the-medicine-dropper-for-eye-injuries","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nano-medicine\/an-end-to-the-medicine-dropper-for-eye-injuries.php","title":{"rendered":"An end to the medicine dropper for eye injuries?"},"content":{"rendered":"<p><p>9 hours ago              <\/p>\n<p>    For years, treating scratches and burns to the eyes has usually    involved dropping medicine onto the eyes several times a day,    sometimes for weeksa treatment that lends itself to missed    doses and other side effects. But scientists are now reporting    in the journal ACS Nano a novel, drug-releasing wafer    that patients can put directly on their affected eyes just once    a day. The team says the device works better than drops and    could help patients recover faster.  <\/p>\n<p>    Ghanashyam Acharya, Stephen C. Pflugfelder and colleagues point    out that eye injuries are a major cause of blindness worldwide.    In the U.S., about 2.5 million people suffer such an injury    every year. But typical eye drop therapies are not very    efficient. Blinking and tears clear the medicine quickly from    the eyes, so patients have to apply drops several times a day.    But this frequency boosts the risks for side effects, including inflammation and blurred    vision, and makes it likely that patients will miss doses.    Researchers have tried many approaches to address these    problems, but none so far have worked well.  <\/p>\n<p>    In a new approach, Acharya's team developed a clear, round    filmwhich for humans would be about one-tenth the size of a    typical contact lensembedded with tiny pockets that can hold    and release medicine slowly over time. The film then    dissolves completely. In mice, the wafer was twice as effective    as eye drops and didn't cause inflammation that can    lead to side effects. The team concludes that the wafer could    be used to treat eye injuries and other conditions    such as chronic dry eye and glaucoma.<\/p>\n<p>     Explore further:     Drug-infused nanoparticle is right for sore eyes  <\/p>\n<p>    More information: Ocular Drug Delivery Nanowafer with    Enhanced Therapeutic Efficacy, ACS Nano, Article ASAP,    DOI: 10.1021\/nn506599f  <\/p>\n<p>    Abstract    Presently, eye injuries are treated by topical eye drop    therapy. Because of the ocular surface barriers, topical eye    drops must be applied several times in a day, causing side    effects such as glaucoma, cataract, and poor patient    compliance. This article presents the development of a    nanowafer drug delivery system in which the polymer and the    drug work synergistically to elicit an enhanced therapeutic    efficacy with negligible adverse immune responses. The    nanowafer is a small transparent circular disc that contains    arrays of drug-loaded nanoreservoirs. The slow drug release    from the nanowafer increases the drug residence time on the    ocular surface and its subsequent absorption into the    surrounding ocular tissue. At the end of the stipulated period    of drug release, the nanowafer will dissolve and fade away. The    in vivo efficacy of the axitinib-loaded nanowafer was    demonstrated in treating corneal neovascularization (CNV) in a    murine ocular burn model. The laser scanning confocal imaging    and RT-PCR study revealed that once a day administered axitinib    nanowafer was therapeutically twice as effective, compared to    axitinib delivered twice a day by topical eye drop therapy. The    axitinib nanowafer is nontoxic and did not affect the wound    healing and epithelial recovery of the ocular burn induced    corneas. These results confirmed that drug release from the    axitinib nanowafer is more effective in inhibiting CNV compared    to the topical eye drop treatment even at a lower dosing    frequency.<\/p>\n<p>      For the millions of sufferers of dry eye syndrome, their only      recourse to easing the painful condition is to use drug-laced      eye drops three times a day. Now, researchers from the      University of Waterloo have ...    <\/p>\n<p>      Honey's antibacterial benefits are widely recognised but now      a QUT team of optometry researchers is conducting clinical      trials of the therapeutic effect of the sweet nectar as a      remedy for dry, red and sore eyes, which are ...    <\/p>\n<p>      Changes in the lipid layer of the eyes' natural tear film may      contribute to the common problem of contact lens discomfort,      reports a study in the December issue of Optometry and Vision      Science, official journal of the Am ...    <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/phys.org\/news342275894.html\/RK=0\/RS=0UDnNstjcTNYt8qcpmdfj0b.VuM-\" title=\"An end to the medicine dropper for eye injuries?\">An end to the medicine dropper for eye injuries?<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> 9 hours ago For years, treating scratches and burns to the eyes has usually involved dropping medicine onto the eyes several times a day, sometimes for weeksa treatment that lends itself to missed doses and other side effects. But scientists are now reporting in the journal ACS Nano a novel, drug-releasing wafer that patients can put directly on their affected eyes just once a day.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nano-medicine\/an-end-to-the-medicine-dropper-for-eye-injuries.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-180584","post","type-post","status-publish","format-standard","hentry","category-nano-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/180584"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=180584"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/180584\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=180584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=180584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=180584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}